View All Reports Email Us

Respiratory Inhalers Market Research Report- Global Forecast To 2023 Respiratory Inhalers Market Research Report- Global Forecast To 2023

  • ID: MRFR/HC/2237-CRR
  • |
  • May, 2017
  • |
  • Region: Global
  • |
  • 111 pages
  • |
  • Cooked Research Reports

Respiratory Inhalers market information, by type (manually operated, digitally operated), by product (dry powder inhaler, metered dose inhaler, and others), by application (asthma, COPD, and other), by end user (hospitals & clinics, respiratory care center, and other) - Forecast to 2023


 


Respiratory Inhalers market by Type, 2016 (USD Million)


 



Market Synopsis of Respiratory Inhalers market:

Market Scenario:


Respiratory disorders have always been a huge challenge for the drug manufacturers and the medical practitioners. In the last couple of decades, this respiratory disorder prevalence has increased tremendously due to some of the reasons such as air pollution, smoking, industrialization among others. To counter these respiratory disorders, scientists have developed various drugs and devices. Extensive efforts have been made to control the disorders such as Asthma and Chronic obstructive pulmonary disorder which affects the majority of the patients. According to WHO, more than 300 million people in the world are affected by asthma and more than 200 million people are affected by the COPD by 2016. Globally the market for respiratory inhalers is growing steadily. Globally the market for respiratory inhaler is expected to grow at the rate of about 6.1% from 2017 to 2023.



Key Finding



  • The respiratory inhalers global market and is expected to reach $33,572.9 million by 2023.

  • Manually Operated Inhalers holds the largest share of 89.9% of the market.

  • North America holds the largest market share of respiratory Inhalers market and is anticipated to reach $11,949.4 million by the end of forecast period.

  • Globally, Asia-Pacific the fastest growing region and expected to grow at the rate of 6.7% during the forecast period.



Segments:                                                                                                                                        

Respiratory Inhalers market has been segmented on the basis of type which comprises of manually operated, digitally operated. Manually operated inhalers accounted for the largest market share of the total market in 2016. On the basis of product, the market is segmented into dry powder inhaler, metered dose inhaler, and others. Dry powder inhalers accounted for the largest market share in 2016. On the basis of application, market is segmented into asthma, COPD, and other. Asthma segment accounted for the largest market share of the total market in 2016. On the basis of end user, market is segmented into hospitals & clinics, respiratory care center, and other. Hospitals & clinics dominated the global market with the largest market share of the total market in 2016.


 


Regional Analysis of Respiratory Inhalers Market:             


Globally North America is the largest market for Respiratory Inhalers accounting 35.1% of the total market. This large share is majorly due to, tobacco smoke which is a key factor in the development and progression of COPD. COPD was considered the third leading cause of death in U.S. in 2014, with almost 6.4% of Americans diagnosed with the disease. Currently most of the inhalers are sold in North America with very less contribution from other regions. North America market is expected to reach $11,949.4 million by 2023. Europe is the second-largest market majorly due to companies or the key players present in the region such as, Novartis, AstraZeneca, and Boehringer Ingelheim. Adoption of respiratory inhalers by hospitals and patients in the European countries, and also due to continuous efforts made by European Academy of Allergy & Clinical Immunology to increase awareness about asthma and COPD the market for respiratory inhalers is expected to show grow in the coming future. European market is expected to reach 11,425.7 by 2023.  Furthermore, Asia-Pacific market is expected to be the fastest growing market for respiratory inhalers due to continuous developments in developing countries like India and China. Emerging economies are expected to accounts for the maximum cases of respiratory disorders, remains unnoticed. Moreover, significant growth in the digitally operated inhalers is observed in the countries like Australia and New Zealand. Asia–Pacific region is expected to grow at 6.7% CAGR during the forecasted period.  On the other hand, Middle East & Africa contributed the least in the global market with only 9.2% share. Middle East & Africa regions are expected to have a limited but steady growth.



Key Players for Respiratory Inhalers Market:      
                                        


Some of the key players in this market are: Adherium limited, AstraZeneca, Boehringer Ingelheim GmbH, Chiesi Farmaceutici S.p.A., GSK plc, Propeller Health, and Teva Pharmaceutical Industries Ltd.  
    


Intended Audience



  • Respiratory Inhaler manufacturers and suppliers

  • Contract Research Organizations (CROs)

  • Research and Development (R&D) Companies

  • Government Research Laboratories

  • Independent Research Laboratories

  • Government and Independent Regulatory Authorities

  • Market Research and Consulting Service Providers

  • Academic Institutes and Universities



The report for
Respiratory Inhalers market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions

1    Report Prologue

2    Market Introduction

2.1    Definition

2.2    Scope of Study

2.3    Research Objective

2.4    Assumptions & Limitations

2.4.1    Assumptions

2.4.2    Limitations

2.5    Market Structure

3    Research Methodology

3.1    Research Process

3.2    Primary Research

3.3    Secondary Research

4    Market Dynamics

4.1    Introducton

4.2    Drivers

4.2.1    Rising prevalence of chronic respiratory disease

4.2.2    Increasing usage of combination therapy

4.2.3    Growing need for rescue medication

4.2.4    Technological advancements

4.3    Restraints

4.3.1    No single, effective device for every respiratory disorders

4.3.2    Side effects and complications during inhalation

4.3.3    High price

4.3.4    Non-standardized dosage

4.4    Opportunities

4.4.1    Advanced products

4.4.2    Increasing demand in developing countries

4.5    Challenges

4.5.1    Strong competition

4.5.2    More advanced products

5    Market Factor Analysis

5.1    Porter’s Five Forces Model

5.1.1    Bargaining power of suppliers

5.1.2    Bargaining Power of Buyers

5.1.3    Threat of New Entrants

5.1.4    Threat of Substitutes

5.1.5    Intensity of Rivalry

6    Global Respiratory Inhalers Market, By Type

6.1    Introduction

6.2    Manually Operated Inhaler

6.3    Digitally Operated Inhaler

7    Global Respiratory Inhalers Market, By Product

7.1    Introduction

7.2    Dry Powder Inhaler

7.3    Metered Dose Inhaler

8    Global Respiratory Inhalers Market, By Application

8.1    Introduction

8.2    Asthma

8.3    COPD

9    Global Respiratory Inhalers Market, By End User

9.1    Introduction

9.2    Hospitals & Clinics

9.3    Respiratory Care Centers

10    Global Respiratory Inhalers Market, By Region

10.1    Introduction

10.2    North America

10.2.1    US

10.2.2    Canada

10.3    Europe

10.3.1    Germany

10.3.2    France

10.3.3    U.K.

10.3.4    Italy

10.3.5    Spain

10.3.6    Rest of Western Europe

10.3.7    Eastern Europe

10.4    Asia-Pacific

10.4.1    Japan

10.4.2    China

10.4.3    India

10.4.4    Republic of Korea

10.4.5    Rest of Asia-Pacific

10.5    Middle East & Africa

10.5.1    Middle East

10.5.2    Africa

11    Competitive Landscape

11.1    Company Share Analysis

12    Company Profiles

12.1    Adherium

12.1.1    Company Overview

12.1.2    Product/Business Overview

12.1.3    Adherium Health: Financials

12.1.4    Key Developments

12.1.5    SWOT Analysis

12.2    AstraZeneca

12.2.1    Company Overview

12.2.2    Product overview

12.2.3    Financial Overview

12.2.4    Key Developments

12.2.5    SWOT Analysis

12.3    Boehringer Ingelheim GmbH

12.3.1    Company Overview

12.3.2    Product Overview

12.3.3    Financial Overview

12.3.4    Key Development

12.3.5    SWOT Analysis

12.4    Chiesi Farmaceutici S.p.A.

12.4.1    Company Overview

12.4.2    Product Overview

12.4.3    Financial Overview

12.4.4    Key Developments

12.4.5    SWOT Analysis

12.5    GlaxoSmithKline

12.5.1    Company Overview

12.5.2    Product overview

12.5.3    Financial Overview

12.5.4    Key Developments

12.5.5    SWOT Analysis

12.6    Propeller Health

12.6.1    Company Overview

12.6.2    Product Overview

12.6.3    Propeller Health: Financials

12.6.4    Key Developments

12.6.5    SWOT Analysis

12.7    Teva Pharmaceutical Industries Ltd

12.7.1    Company Overview

12.7.2    Product Overview

12.7.3    Financial Overview

12.7.4    Key Developments

12.7.5    SWOT Analysis

List of Tables    

    

TABLE 1    GLOBAL RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)

TABLE 2    GLOBAL MANUALLY OPERATED INHALER MARKET, BY REGION, 2014-2023 (USD MILLION)

TABLE 3    GLOBAL DIGITALLY OPERATED INHALER MARKET, BY REGION, 2014-2023 (USD MILLION)

TABLE 4    GLOBAL RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)

TABLE 5    GLOBAL DRY POWDER INHALER MARKET, BY REGION, 2014-2023 (USD MILLION)

TABLE 6    GLOBAL METERED DOSE INHALER MARKET, BY REGION, 2014-2023 (USD MILLION)

TABLE 7    GLOBAL RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)

TABLE 8    GLOBAL RESPIRATORY INHALER MARKET FOR ASTHMA, BY REGION, 2014-2023 (USD MILLION)

TABLE 9    GLOBAL RESPIRATORY INHALER MARKET FOR COPD, BY REGION, 2014-2023 (USD MILLION)

TABLE 10    GLOBAL RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)

TABLE 11    GLOBAL RESPIRATORY MARKET FOR HOSPITAL, BY REGION, 2014-2023 (USD MILLION)

TABLE 12    GLOBAL RESPIRATORY INHALER MARKET FOR RESPIRATORY CARE CENTERS, BY REGION,

2014-2023 (USD MILLION)    39

TABLE 13    GLOBAL RESPIRATORY INHALERS MARKET, BY REGION, 2014-2023 (USD MILLION)

TABLE 14    NORTH AMERICA RESPIRATORY INHALERS MARKET, BY COUNTRY, 2014-2023 (USD MILLION)

TABLE 15    NORTH AMERICA RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)

TABLE 16    NORTH AMERICA RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)

TABLE 17    NORTH AMERICA RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)

TABLE 18    NORTH AMERICA RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)

TABLE 19    US RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)

TABLE 20    US RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)

TABLE 21    US RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)

TABLE 22    US RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)

TABLE 23    CANADA RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)

TABLE 24    CANADA RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)

TABLE 25    CANADA RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)

TABLE 26    CANADA RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)

TABLE 27    EUROPE RESPIRATORY INHALERS MARKET, BY COUNTRY, 2014-2023 (USD MILLION)

TABLE 28    EUROPE RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)

TABLE 29    EUROPE RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)

TABLE 30    EUROPE RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)

TABLE 31    EUROPE RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)

TABLE 32    GERMANY RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)

TABLE 33    GERMANY RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)

TABLE 34    GERMANY RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)

TABLE 35    GERMANY RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)

TABLE 36    FRANCE RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)

TABLE 37    FRANCE RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)

TABLE 38    FRANCE RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)

TABLE 39    FRANCE RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)

TABLE 40    U.K. RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)

TABLE 41    U.K. RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)

TABLE 42    U.K. RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)

TABLE 43    U.K. RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)

TABLE 44    ITALY RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)

TABLE 45    ITALY RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)

TABLE 46    ITALY RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)

TABLE 47    ITALY RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)

TABLE 48    SPAIN RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)

TABLE 49    SPAIN RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)

TABLE 50    SPAIN RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)

TABLE 51    SPAIN RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)

TABLE 52    REST OF WESTERN EUROPE RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)

TABLE 53    REST OF WESTERN EUROPE RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)

TABLE 54    REST OF WESTERN EUROPE RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)

TABLE 55    REST OF WESTERN EUROPE RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)

TABLE 56    EASTERN EUROPE RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)

TABLE 57    EASTERN EUROPE RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)

TABLE 58    EASTERN EUROPE RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)

TABLE 59    EASTERN EUROPE RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)

TABLE 60    ASIA-PACIFIC RESPIRATORY INHALERS MARKET, BY COUNTRY, 2014-2023 (USD MILLION)

TABLE 61    ASIA-PACIFIC RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)

TABLE 62    ASIA-PACIFIC RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)

TABLE 63    ASIA-PACIFIC RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)

TABLE 64    ASIA-PACIFIC RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)

TABLE 65    JAPAN RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)

TABLE 66    JAPAN RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)

TABLE 67    JAPAN RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)

TABLE 68    JAPAN RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)

TABLE 69    CHINA RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)

TABLE 70    CHINA RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)

TABLE 71    CHINA RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)

TABLE 72    CHINA RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)

TABLE 73    INDIA RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)

TABLE 74    INDIA RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)

TABLE 75    INDIA RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)

TABLE 76    INDIA RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)

TABLE 77    REPUBLIC OF KOREA RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)

TABLE 78    REPUBLIC OF KOREA RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)

TABLE 79    REPUBLIC OF KOREA RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)

TABLE 80    REPUBLIC OF KOREA RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)

TABLE 81    REST OF ASIA-PACIFIC RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)

TABLE 82    REST OF ASIA-PACIFIC RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)

TABLE 83    REST OF ASIA-PACIFIC RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)

TABLE 84    REST OF ASIA-PACIFIC RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)

TABLE 85    MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET, BY REGION, 2014-2023 (USD MILLION)

TABLE 86    MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)

TABLE 87    MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)

TABLE 88    MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)

TABLE 89    MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)

TABLE 90    MIDDLE EAST RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)

TABLE 91    MIDDLE EAST RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)

TABLE 92    MIDDLE EAST RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)

TABLE 93    MIDDLE EAST RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)

TABLE 94    AFRICA RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)

TABLE 95    AFRICA RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)

TABLE 96    AFRICA RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)

TABLE 97    AFRICA RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)

TABLE 98    ADHERIUM: KEY DEVELOPMENTS

TABLE 99    ASTRAZENECA: PRODUCT OVERVIEW

TABLE 100    ASTRAZENECA: KEY DEVELOPMENTS

TABLE 101    BOEHRINGER INGELHEIM GMBH: PRODUCT OVERVIEW

TABLE 102    BOEHRINGER INGELHEIM GMBH: KEY DEVELOPMENTS

TABLE 103    CHIESI FARMACEUTICI S.P.A: PRODUCT OVERVIEW

TABLE 104    CHIESI FARMACEUTICI S.P.A: KEY DEVELOPMENTS

TABLE 105    GLAXOSMITHKLINE PLC: PRODUCT OVERVIEW

TABLE 106    GLAXOSMITHKLINE PLC: KEY DEVELOPMENTS

TABLE 107    PROPELLER HEALTH: PRODUCT/SERVICES OVERVIEW

TABLE 108    PROPELLER HEALTH: KEY DEVELOPMENTS

TABLE 109    TEVA PHARMACEUTICAL INDUSTRIES LTD: RECENT FINANCIALS

TABLE 110    TEVA PHARMACEUTICAL INDUSTRIES LTD: KEY DEVELOPMENTS

List of Figures    

    

FIGURE 1    GLOBAL RESPIRATORY INHALER MARKET SHARE, BY TYPE, 2016 (%)

FIGURE 2    GLOBAL RESPIRATORY INHALER MARKET SHARE, BY PRODUCT, 2016 (%)

FIGURE 3    GLOBAL RESPIRATORY INHALER MARKET SHARE, BY APPLICATION, 2016 (%)

FIGURE 4    GLOBAL RESPIRATORY INHALER MARKET SHARE, BY END USER, 2016 (%)

FIGURE 5    GLOBAL RESPIRATORY INHALER MARKET SHARE, BY REGION, 2016 (%)

FIGURE 6    MARKET STRUCTURE OF GLOBAL RESPIRATORY INHALER MARKET

FIGURE 7    RESEARCH PROCESS OF MRFR

FIGURE 8    DROC OF GLOBAL RESPIRATORY INHALERS MARKET

FIGURE 9    PORTERS FIVE FORCES MODEL

FIGURE 10    GLOBAL RESPIRATORY INHALERS MARKET, BY TYPE, 2016 & 2023 (USD MILLION)

FIGURE 11    GLOBAL RESPIRATORY INHALERS MARKET, BY PRODUCT, 2016 & 2023

FIGURE 12    GLOBAL RESPIRATORY INHALERS MARKET, BY APPLICATION, 2016 & 2023 (USD MILLION)

FIGURE 13    GLOBAL RESPIRATORY INHALERS MARKET, BY END USER, 2016 & 2023 (USD MILLION)

FIGURE 14    GLOBAL RESPIRATORY INHALERS MARKET SHARE, BY REGION, 2016 (%)

FIGURE 15    NORTH AMERICA RESPIRATORY INHALERS MARKET SHARE, BY COUNTRY, 2016 (%)

FIGURE 16    EUROPE RESPIRATORY INHALERS MARKET SHARE, BY COUNTRY, 2016 (%)

FIGURE 17    ASIA-PACIFIC RESPIRATORY INHALERS MARKET SHARE, BY COUNTRY, 2016 (%)

FIGURE 18    MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET, BY REGION, 2016 (%)

FIGURE 19    GLOBAL RESPIRATORY INHALER MARKET: COMPANY SHARE ANALYSIS, 2016 (%)

FIGURE 20    ADHERIUM: SWOT ANALYSIS

FIGURE 21    ASTRAZENECA: RECENT FINANCIAL

FIGURE 22    ASTRAZENECA: GEOGRAPHICAL MIX, 2016 (%)

FIGURE 23    ASTRAZENECA: OPERATING SEGMENTS, 2016 (%)

FIGURE 24    ASTRAZENECA: RESPIRATORY SEGMENT MIX, 2016 (%)

FIGURE 25    ASTRAZENECA: SWOT ANALYSIS

FIGURE 26    BOEHRINGER INGELHEIM GMBH: RECENT FINANCIALS

FIGURE 27    BOEHRINGER INGELHEIM GMBH: GEOGRAPHICAL MIX, 2016 (%)

FIGURE 28    BOEHRINGER INGELHEIM GMBH: OPERATING SEGMENTS, 2016 (%)

FIGURE 29    BOEHRINGER INGELHEIM GMBH: SWOT ANALYSIS

FIGURE 30    CHIESI FARMACEUTICI S.P.A: RECENT FINANCIALS

FIGURE 31    CHIESI FARMACEUTICI S.P.A: GEOGRAPHICAL MIX, 2015 (%)

FIGURE 32    CHIESI FARMACEUTICI S.P.A: RESPIRATORY SEGMENT MIX, 2016 (USD MILLION)

FIGURE 33    CHIESI FARMACEUTICI S.P.A: SWOT ANALYSIS

FIGURE 34    GLAXOSMITHKLINE: RECENT FINANCIALS

FIGURE 35    GLAXOSMITHKLINE PLC: GEOGRAPHICAL MIX, 2016 (%)

FIGURE 36    GLAXOSMITHKLINE PLC: OPERATING SEGMENTS, 2016 (%)

FIGURE 37    GLAXOSMITHKLINE PLC: PHARMACEUTICAL BUSINESS MIX, 2016 (%)

FIGURE 38    GLAXOSMITHKLINE: SWOT ANALYSIS

FIGURE 39    PROPELLER HEALTH: SWOT ANALYSIS

FIGURE 40    TEVA PHARMACEUTICAL INDUSTRIES LTD: GEOGRAPHICAL MIX, 2016 (%)

FIGURE 41    TEVA PHARMACEUTICAL INDUSTRIES LTD: OPERATING SEGMENTS, 2016 (%)

FIGURE 42    TEVA PHARMACEUTICAL INDUSTRIES LTD: SWOT ANALYSIS

captcha
Please enter code
captcha
Please enter code

Contact Us

Email Us at: salesteam@marketresearchfuture.com | Reach Us at: + (646) 845 9349 (US), +44 208 133 9349 (uk)